Columbia, Maryland, September 24, 2019 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in events at prominent diabetes and healthcare conferences this Fall. The list of events is as follows:
DTx East: Defining Digital Therapeutic Integration Into Healthcare
September 24-26, 2019, Harvard Medical School, Boston, MA
Anand Iyer, Welldoc Chief Strategy Officer, will be moderating a panel on “The Digital Therapeutics Engagement Chain” with 5 of Welldoc’s payer clients. The presentation is on Thursday, September 26th at 10:20 a.m. ET.
Annual Meeting of AADE Virginia Coordinating Body
October 3-4, 2019, The Place at Innsbrook, Richmond, VA
Malinda Peeples, Welldoc’s VP of Clinical Services, Programs and Research, will be presenting “Digital Health & Diabetes through the Lens of Minimally Disruptive Medicine” on Friday, October 4th at 2 p.m. ET.
Primary Care Conference
October 5, 2019, Harvard Medical School, Boston, MA
Malinda Peeples, Welldoc’s VP of Clinical Services, Programs and Research, and Welldoc’s Director of Client Implementation Vinayak Shenoy will be exhibiting.
AADE Technology Summit
October 21-22, 2019, Chicago, IL
Malinda Peeples, Welldoc’s VP of Clinical Services, Programs and Research, will be presenting “Digital Health & Population Health.”
XCON: Digital Health Gets Real
October 22, 2019, deCordova Sculpture Park and Museum, Lincoln, MA
Welldoc CEO Kevin McRaith will present on a panel “Building a Market for Digital Therapeutics” alongside Akili Interactive Labs Co-founder and CEO Eddie Martucci, and Pear Therapeutics CEO Corey McCann at 10:10 a.m. ET.
HLTH: Welldoc Exhibiting at Booth #311
October 26-30, 2019, MGM Grand Conference Center, Las Vegas, NV
Welldoc will be well-represented at HLTH this year in the exhibit hall at booth #311 and at several speaking opportunities, including:
- Panel Discussion: Providers Betting on Telehealth: From RPM to Primary Care and Digital Therapeutics
Sunday, October 27th at 10:25 – 11:15 am
Virtual care and the emerging field of digital therapeutics (DTx) are solving many of our biggest challenges, addressing a wide range of conditions across the spectrum of care, including behavioral health, chronic disease management and other complex/specialty care conditions. Telehealth is also expanding into primary care and being imbedded into population health management programs that are winning over front-line provider, hospitals and delivery systems. Learn why telehealth is fast becoming the front-runner in the race to redesigning healthcare delivery. - Track 5 Drug-less Therapy: Therapy Gone Digital
Sunday, October 27th at 3:10 to 3:50 p.m.
Moderator Steven Collens, CEO of MATTER FORMAT, will be talking with Anand Iyer; Matt Omernick, Akili Interactive Co-founder and Chief Creative Officer; Acacia Parks, Chief Scientist of Happify Health; and Pablo Pantaleoni, Vice President and General Manager of Headspace.
Clinically validated, FDA approved and consumer verified digital therapies are giving those suffering a new route to relief. Leaders will share proven successes and future plans for digital therapies that maximize patients’ drug adherence and improve outcomes at impressive levels. - Demystifying the Digital Therapeutics Ecosystem
Wednesday, October 30th at Noon to 2 p.m.
Evercore sponsored a group discussion on how innovative companies are merging technology with evidence-based medicine. Ross Muken, a leading healthcare equity analyst at Evercore, will moderate 4 key topics on digital therapeutics. Welldoc’s Chief Revenue Officer Jen Cressman was invited to discuss “Opportunities for Partnership Across the Digital Therapy Continuum.”
AMCP Nexus 2019! Find Yourself at the Intersection of Value and Care
October 31-November 1, 2019, Gaylord National Harbor, MD
Malinda Peeples, Welldoc’s VP of Clinical Services, Programs and Research, will be presenting on the panel “Future Trends in Health Technology and Digital Therapeutics” on Friday, November 1st at 8:00 a.m. ET.
19th Annual Diabetes Technology Meeting
November 14-16, 2019, Bethesda North Marriott & Conference Center, Bethesda, MD
Welldoc Medical Director Mansur E. Shomali, MD, CM will present the poster “Contextual Annotations Predict Persistence and Diabetes Outcomes with a Digital Therapeutic.”
American Heart Association Scientific Sessions
November 16-18, 2019, Sheppard Pratt Conference Center, Baltimore, MD
Welldoc Medical Director Mansur E. Shomali, MD, CM, will present “Enhancing Mobile Health to Achieve Both Hypertension and Diabetes Goals” at 11:00 a.m. ET.
American Diabetes Association: Diabetes is Primary
November 21, 2019, Sheppard Pratt Conference Center, Baltimore, MD
Welldoc Medical Director Mansur E. Shomali, MD, CM, will present “Cardiovascular Disease in Type 2 Diabetes” at 1:30 p.m. ET.
Clinically Validated Digital Therapeutics Summit
December 4-5, 2019, Boston, MA
Welldoc Chief Strategy Officer Anand Iyer will present “Digital Therapeutics Engagement Chain: Key Success Factors” on December 5th at 11:00 a.m. EST.
About Welldoc®
Welldoc® is a leading digital therapeutic company revolutionizing chronic disease management to help transform lives. The Company’s groundbreaking technology helps guide individuals through the complicated journey of living with chronic diseases, with a goal of helping them self-manage their conditions, while connecting them to their own healthcare team. By utilizing Welldoc’s digital therapeutic solutions, payers, employers and healthcare systems can streamline their resources by focusing on a digital health solution to help better manage their populations living with multiple and costly chronic diseases. Welldoc is based on a life science business model—having conducted multiple randomized clinical trials resulting in more than 40 peer-reviewed publications. BlueStar has been recognized by IQVIA in 2017 as the “Top App” for type 2 diabetes treatment, awarded Diabetes Technology Society’s 2019 Digital Diabetes Congress Mobile App Contest in the “Established App” category, and MedTech Breakthrough’s 2019 “Best Personal Health App” award. Welldoc has a solid foundation in the development of solutions for the management of diabetes and is rapidly creating other chronic disease solutions. This year, Welldoc secured a patent for the Software Engine Technology that powers BlueStar. Notably, this is the Company’s tenth issued patent. For more information, visit www.welldoc.com.
